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Abstract
A protein quality control system, consisting of molecular chaperones and proteases, controls the
folding status of proteins and prevents the aggregation of misfolded proteins by either refolding or
degrading aggregation-prone species. During severe stress conditions this protection system can
be overwhelmed by high substrate load, resulting in the formation of protein aggregates. In such
emergency situations, Hsp104/ClpB becomes a key player for cell survival, as it has the
extraordinary capacity to rescue proteins from an aggregated state in cooperation with an Hsp70
chaperone system. The ring-forming Hsp104/ClpB chaperone belongs to the AAA+ protein
superfamily, which in general drives the assembly and disassembly of protein complexes by ATP-
dependent remodelling of protein substrates. A disaggregation activity was also recently attributed
to other eubacterial AAA+ proteins, while such an activity has not yet been identified in mammalian
cells. In this review, we report on new insights into the mechanism of protein disaggregation by
AAA+ proteins, suggesting that these chaperones act as molecular crowbars or ratchets.
Review
Holding and folding: Molecular chaperones in protein 
quality control systems
The viability of all organisms crucially depends on the
integrity and the correlated activity of its constituent pro-
teins, stressing the fundamental importance of correctly
folded proteins. While the information for a three-dimen-
sional protein structure is provided by its corresponding
primary amino acid sequence, the folding process is, how-
ever, sensitive to external parameters such as temperature,
solvent properties or the concentration of macromole-
cules in solution. Given the high degree of molecular
crowding in cells (340 gL-1 macromolecules) [1] and the
exposure of hydrophobic residues during the de novo fold-
ing of newly synthesized polypeptides, proteins can be
trapped during the folding process in misfolded interme-
diates that are prone to aggregation. In particular, large
multidomain and oligomeric proteins encounter this
problem, as they tend to follow a slow folding pathway.
Even once a protein has achieved its correct conformation
it is still subject to several forms of stress that interfere
with its structural integrity. These include physical and
chemical influences that can result in protein unfolding,
such as changes in temperature or ionic strength, oxida-
tive stress or the presence of heavy metals.
To cope with these stresses a group of highly conserved
proteins has evolved, specialized in assisting the folding
of nascent polypeptides and the refolding of misfolded
proteins. This protein class was first discovered as part of
the heat shock response as the gene expression of its mem-
bers was stimulated by the exposure of cells to heat [2].
These effector molecules were therefore termed heat shock
proteins (Hsp) and later on defined as molecular chaper-
ones. Chaperones control the folding status of proteins
and, together with ATP-dependent proteases, form the
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Prevention and reversion of protein aggregation by chaperones and proteases in eubacteria Figure 1
Prevention and reversion of protein aggregation by chaperones and proteases in eubacteria. Protein aggregation is caused by 
misfolded protein species and can be facilitated by overproduction of heterologous proteins, thermal or oxidative stress and 
protein mutations affecting protein folding. Formation of protein aggregates can be prevented either by Hsp60 or Hsp70-medi-
ated refolding of aggregation-prone substrates or by removal of the misfolded protein species by proteolytic systems (Lon, 
ClpAP, ClpCP/MecA). High levels of misfolded proteins can overburden the capacity of chaperones and proteases, leading to 
protein aggregation. Aggregated proteins are rescued by the Hsp104/Hsp70 or the ClpB/DnaK bi-chaperone systems. Protein 
aggregates can also be solubilized by ClpCP/MecA or ClpAP (+/- ClpS) resulting in substrate hydrolysis.
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cellular protein quality control system (Fig. 1). Depend-
ing on their function, chaperones can be classified into
"holder" or "folder" chaperones. Holder chaperones (e.g.
small Hsps) can prevent the aggregation of misfolded pro-
tein species without mediating protein reactivation.
Folder chaperones (e.g. Hsp60/GroEL, Hsp70/DnaK) in
addition support substrate refolding (for review see [3]).
However, the capacity of chaperones to protect misfolded
proteins is limited. High levels of misfolded proteins can
exceed the buffering capacity of chaperones, leading to
protein aggregation. Protein aggregation is facilitated by
partial unfolding during thermal or oxidative stress, by
overproduction of heterologous proteins and/or by alter-
ations in primary structure caused by mutation (Fig. 1).
The terms "inclusion bodies" and "aggresomes" have
been applied to intracellular foci into which aggregated
proteins are sequestered [4]. The toxicity of protein aggre-
gates is unclear. It is possible that the aggregates may dis-
turb the fine-tuned folding equilibrium of cellular
proteins by affecting their folding status or by sequester-
ing molecular chaperones. Massive protein aggregation
that occurs during severe stress conditions can therefore
cause damage of cellular structures and metabolism,
resulting in cell death. Since the ability of classical chaper-
ones to rescue proteins from an aggregated state is limited,
protein aggregates were once viewed as "dead ends" in the
life cycle of proteins.
The discovery of Hsp104: a chaperone with unique 
activities
In 1990 Susan Lindquist and co-workers discovered a new
Hsp gene of Saccharomyces cerevisiae, termed HSP104, and
its involvement in induced thermotolerance [5]. It was
shown that upon mild pre-heat treatment (37°C) S. cere-
visiae cells could subsequently survive extreme tempera-
tures (50°C). In contrast, ∆hsp104 mutant cells did not
exhibit an adaptation to extreme temperatures and
instead died with a rate up to 1000-fold faster than wild
type cells. This defect could be entirely rescued through
transformation of the HSP104 wild type gene, proving the
dependence of thermotolerance development on Hsp104.
It could be further demonstrated that Hsp104 is required
for tolerance to many different forms of stress such as eth-
anol, arsenite or long-term storage of the yeast cells at low
temperatures [6]. Even more striking was the finding that
large electron-dense aggregates that formed after heat
shock in the nucleus and the cytoplasm of S. cerevisiae
were the main target of Hsp104 action [7]. S. cerevisiae
cells expressing Hsp104 were able to resolubilize these
aggregates, thus regaining the function of the affected pro-
teins as demonstrated for the model substrate luciferase.
Importantly Hsp104 was unable to prevent the aggrega-
tion of chemically denatured luciferase, differentiating it
from classical chaperones [7]. These findings opened a
new chapter in the understanding of molecular chaper-
ones as their activities had been so far believed to be
restricted to preventing the aggregation of misfolded pro-
tein species. The more defensive action of the classical
holder and folder chaperones was now complemented by
Hsp104's ability to act on aggregated proteins.
This extraordinary activity explains the cell's capacity to
offensively cope with severe stress conditions that lead to
protein aggregation. The unique function of Hsp104 is
conserved in eubacteria, plants and mitochondria by its
homologues ClpB, Hsp101 and Hsp78, which each are
essential for thermotolerance and protein disaggregation
[8-13]. The ability of these organisms and organelles to
adapt to severe stress conditions relies on the activity of
Hsp104/ClpB to reverse protein aggregation.
From a subfamily of heat shock proteins to a superfamily 
of AAA+ proteins
Through sequence alignments Hsp104/ClpB could be first
assigned to the conserved Hsp100/Clp protein family, a
group of ring-forming ATPases [14]. Neuwald and col-
leagues found that Hsp100/Clp proteins and AAA pro-
teins (ATPase associated with a variety of cellular
activities) share conserved motifs involved in ATP binding
and hydrolysis and they combined both protein classes to
generate a new protein superfamily: the AAA+ proteins
[15]. Generally, AAA+ proteins remodel target substrates
in an ATP-dependent manner, an activity that is of central
importance for a large number of cellular processes
[16,17]. AAA+ proteins share a common ATPase domain
with a conserved sequence of 230–250 amino acid resi-
dues, termed the AAA domain. Each AAA domain consists
of a core ATPase domain, containing the classical Walker
A and B motifs, and a C-terminal α-helical domain. The
structural features of this superfamily were confirmed by
structure determinations of AAA domains of various pro-
teins [18-24]. AAA domains mediate the oligomerization
of AAA+ proteins, ATP binding and ATP hydrolysis.
Depending on the number of AAAdomains, AAA+ pro-
teins can be divided into two subgroups. Class I AAA+
proteins consist of two AAA domains, whereas class II
members possess only one [14].
Hsp104/ClpB belongs to class I and the functionality of
each of its AAA domains (AAA-1 and AAA-2) is crucial for
efficient protein disaggregation (Fig. 2A) [25-29]. The
recently published crystal structure of Thermus ther-
mophilus ClpB in complex with AMPPNP shows that the
structure and overall topology of the AAA domains is sim-
ilar to that of E. coli ClpA (Fig. 2B) [18,24]. In a hexameric
ClpB model based on single particle reconstitution by
electron microscopy, the AAA domains are oriented in a
head-to-tail arrangement and AAA-1 is located directly
above AAA-2 of the same subunit [24]. AMPPNP is boundMicrobial Cell Factories 2004, 3 http://www.microbialcellfactories.com/content/3/1/1
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Structural features of AAA+ proteins Figure 2
Structural features of AAA+ proteins. (A) Domain organization and cooperating proteins of AAA+ chaperones. N-terminal 
domains of AAA+ proteins are diverse and are in most cases involved in substrate recognition, either directly or indirectly by 
serving as a binding platform for adaptor proteins. In the case of Torsin A, the N-domain represents a membrane-spanning 
region. The first AAA domains of ClpB and ClpC are interrupted by a middle domain (M-domain) of variable length. ClpP-asso-
ciation of ClpA, ClpC and ClpX is mediated by a conserved docking site (P). Adaptor proteins, cooperating proteins and func-
tions of the corresponding AAA+ proteins are given. The ClpX adaptor proteins SspB, RssB and UmuD target SsrA-tagged 
proteins, the alternative sigma factor σS and UmuD' for degradation by ClpXP, respectively [90-93]. (B) Structure of mono-
meric T. thermophilus ClpB and E. coli ClpA. The colour code of the individual domains is equivalent to (A). AMPPNP (ClpB) or 
ADP (ClpA) is shown as CPK model in grey.
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at the interface of neighbouring subunits in the oligo-
meric model and a conserved arginine residue, termed
"arginine finger", is contacting the γ-phosphate from an
adjacent ClpB molecule. This interaction serves to sense
the state of bound nucleotide in the neighbouring subunit
and can therefore explain the observed cooperativity in
ATP hydrolysis within the Hsp104 and T. thermophilus
ClpB oligomer [30,31]. E. coli ClpB mutants with muta-
tional alterations of the "arginine finger" in either the first
or the second AAA domain are deficient in protein disag-
gregation, demonstrating that this motif in each of the
domains is important for ClpB function [26].
Hsp104/ClpB: an AAA+ protein with unique features
In addition to their AAA domains AAA+ proteins also con-
tain variable regions at their N-termini. N-domains of
Hsp104/ClpB are homologous to those of ClpA and ClpC
and form independent structural domains that are con-
nected via flexible linkers to AAA-1 (Fig. 2A/2B) [24,32].
Comparison of the individual ClpB molecules present in
the asymmetric ClpB crystal unit revealed that the N-
domains are highly mobile and possess a large degree of
rotational freedom [24]. The function of the N-domains
in ClpB-mediated protein disaggregation is still enig-
matic. While ClpB variants carrying point mutations in
the N-domain exhibited a reduced disaggregation activity,
ClpB deletion variants from various sources missing the
entire N-domain were as active as the full-length proteins
[26,32-35]. The existence of ClpB homologues lacking the
N-domain in Mycoplasma sp. also argues against an essen-
tial function of N-domains in the disaggregation process
[36,37]. Therefore N-domains of ClpB may rather be
involved in other more specialized ClpB functions that are
distinct from protein disaggregation.
The most striking feature of Hsp104/ClpB is the presence
of a middle domain (M-domain) that is absent in ClpA,
the closest homologue of ClpB in E. coli (Fig. 2A/2B).
While not directly involved in Hsp104/ClpB oligomeriza-
tion, the M-domains possess an essential function in pro-
tein disaggregation [26,38]. The dependence of the
disaggregation reaction on Hsp104/ClpB in vivo under-
lines the crucial role of this unique domain in the solubi-
lization process. A major step in understanding the M-
domain function was achieved by structure determination
of Thermus thermophilus ClpB [24]. The M-domain forms a
large coiled-coil structure that resembles a two-bladed
propeller (Fig. 2B). In a hexameric ClpB model, the M-
domains are located adjacent to AAA-1 on the outer sur-
face of the molecule [24]. Interestingly, the M-domains
exhibited a high degree of mobility as revealed by super-
position of the individual ClpB molecules present in the
asymmetric ClpB crystal unit. M-domain mobility was
demonstrated to be crucial for protein disaggregation, as
inhibition of M-domain motion caused a loss of ClpB
chaperone activity without affecting ClpB oligomeriza-
tion and ATPase activity [24]. These findings led to the
suggestion that the M-domains may serve as molecular
crowbars that modulate the structure of protein aggregates
(see below). Multiple contacts between the M-domain
and exposed peptide segments on the aggregate surface
may also serve as a scanning device for aggregated pro-
teins. Direct evidence for interactions between M-
domains and aggregated proteins is still missing and such
binding might be difficult to detect given the often tran-
sient nature of AAA+ protein-substrate interaction.
In contrast to many other prokaryotic AAA+ proteins that
are key players in the cellular protein quality control sys-
tem, ClpB is not involved in proteolysis. AAA+ proteins
that are implicated in proteolysis usually associate with
peptidases to form proteolytic systems that resemble the
eukaryotic proteasome. The AAA+ subunits of these pro-
tease complexes function as regulatory components since
they control the access of substrates to the proteolytic
chamber of the associated peptidase. The association of
the AAA+ component (e.g. ClpA, ClpC, ClpX) with the
peptidase (e.g. ClpP) is mediated by a conserved docking
site (Fig. 2A). The signature motif (LIV-G-FL) is present in
the AAA domains of all ClpP-interacting AAA+ proteins
and is located distal to their substrate binding site [39].
Importantly, ClpB is lacking the signature motif and, as a
consequence, ClpB is not involved in proteolysis, yet is
able to act in protein reactivation.
Crowbars and ratchets: potential activities of Hsp104/
ClpB
Which specific activities enable Hsp104/ClpB to reverse
protein disaggregation? The unique function of Hsp104/
ClpB combined with the determined characteristics of the
Hsp104/ClpB-specific M-domain led to the suggestion of
a crowbar activity. This model suggests that movements of
the M-domains of Hsp104/ClpB cause changes in the
aggregate structure and/or a conversion of large protein
aggregates into smaller species (Fig. 3) [24,40,41]. Frag-
mentation of large aggregates by the postulated crowbar
mechanism has not yet been demonstrated as Hsp104/
ClpB-mediated changes in the aggregate might be rather
transient in the absence of additional chaperone systems.
In the case of peptidase-associated AAA+ proteins, a
ratchet mechanism that mediates the unfolding and trans-
location of bound substrates has been proposed [42]. Key
players of this postulated activity are conserved aromatic
residues that are located at the central pore of AAA+ pro-
teins. These aromates may serve as molecular clamps by
binding and releasing substrates, thereby preventing the
backsliding of polypeptides during the translocation proc-
ess. It has been further suggested that nucleotide-depend-
ent conformational changes of these residues directlyMicrobial Cell Factories 2004, 3 http://www.microbialcellfactories.com/content/3/1/1
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couple substrate translocation to substrate unfolding [42].
Consistent with such an activity, the corresponding aro-
matic residues in HslU and FtsH have been shown to be
crucial for substrate degradation [43,44]. Interestingly, the
aromatic residues and their relative positioning are con-
served in both AAA domains of Hsp104/ClpB [41]. Fur-
thermore, these residues appear to be located on mobile
loops, as the corresponding regions could not be resolved
in the ClpB crystal structure [24]. These observations sug-
gest that Hsp104/ClpB may, like peptidase-associated
AAA+ proteins, exhibit a translocation activity that could
mediate the extraction of an unfolded polypeptide from
the aggregate (Fig. 3). A translocation activity of Hsp104/
ClpB as part of the protein disaggregation reaction and a
role of the aromatic residues in such an activity still needs
to be investigated. It is important to note that the poten-
tial crowbar and translocation activities of Hsp104/ClpB
are not mutually exclusive but rather may act sequentially
or in concert, resulting in efficient protein disaggregation.
The missing partner: Hsp70 systems cooperate with 
Hsp104/ClpB in reversing protein aggregation
While the dependence of protein disaggregation in vivo on
Hsp104/ClpB could be established for various organisms,
the reconstitution of this activity in vitro failed for a long
time. Incubation of aggregated proteins with either
Hsp104 or ClpB alone did not result in aggregate solubi-
lization. A breakthrough was made by Glover and
Lindquist, when they demonstrated that Hsp104 needs
the assistance of an Hsp70 system to reverse protein aggre-
gation [40]. The disaggregation activity of this novel bi-
chaperone system could be subsequently established for
Potential mechanisms of protein disaggregation by Hsp104/ClpB Figure 3
Potential mechanisms of protein disaggregation by Hsp104/ClpB. Hsp104/ClpB may break large aggregates into smaller species 
via a crowbar activity, mediated by movements of M-domains. Small-sized aggregates serve as substrates for Hsp70/DnaK in a 
sequential reaction. Hsp104/ClpB may also extract unfolded proteins from an aggregate via a translocation activity with major 
contributions of pore-located aromatic residues (Y). Hsp70/DnaK may directly take over the translocated polypeptide, thereby 
preventing the re-aggregation of extracted proteins and ensuring substrate refolding. Both suggested Hsp104/ClpB activities 
are not mutually exclusive, but rather may act sequentially or in concert.
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the E. coli and T. thermophilus chaperone homologues [45-
47]. The essential role of the Hsp70 chaperone system in
protein disaggregation was also confirmed in vivo, as E.
coli ∆dnaK mutant cells could no longer solubilize aggre-
gated proteins formed during heat shock [8].
The precise mechanism of Hsp104/Hsp70 or ClpB/DnaK
cooperation during protein disaggregation is unknown;
however there are two working models. The first model
proposes a sequential action of both chaperones [45].
Hsp70/DnaK are suggested to act on small-sized protein
aggregates, generated by the postulated crowbar activity of
ClpB (Fig. 3). This model is supported by the findings that
Hsp70/DnaK are able to solubilize small protein aggre-
gates in the absence of Hsp104/ClpB [40,48].
The second model relies on the observation that coopera-
tion of the two chaperone systems exists only between
proteins of the same species [40,49]. Thus, mixtures of S.
cerevisiae Hsp104 and E. coli DnaK (and vice versa) do not
function in protein disaggregation. Interestingly, species-
specificity can be directly attributed to the Hsp70 chaper-
ones as the Hsp40 co-chaperones (Ydj1, DnaJ) of the
individual species can be exchanged without loosing dis-
aggregation activity. These findings suggest that the solu-
bilization of protein aggregates is achieved by the
simultaneous action of a Hsp104/Hsp70 or a ClpB/DnaK
complex. The role of Hsp70/DnaK in such a potential
complex is still unclear. Hsp70/DnaK might be necessary
to accept translocated substrates directly from Hsp104/
ClpB, ensuring efficient substrate translocation and
refolding (Fig. 3). Such an activity would be reminiscent
to the function of AAA+ proteins that are associated with
peptidases, but links Hsp104/ClpB activity to protein
refolding instead of substrate degradation. Direct evi-
dence in support of either model is still missing. Clearly,
the determination of Hsp70/DnaK positioning in the dis-
aggregation process will help to clarify the mechanism of
the Hsp104/ClpB-mediated solubilization process.
Protein disaggregation by other AAA+ proteins
While the solubilization of aggregated proteins in E. coli
cells is dominated by ClpB, a disaggregation activity could
be also assigned to other AAA+ proteins (Fig. 1). E. coli
ClpA can, in complex with the peptidase ClpP, solubilize
heat-aggregated MDH and firefly luciferase in vitro [50].
ClpA is homologous to ClpB, but is missing the ClpB-spe-
cific middle domain (Fig. 2A/2B). The ability of ClpAP to
degrade aggregated proteins implies that protein disaggre-
gation can, in principal, be achieved by a "translocation
only" mechanism. The disaggregation activity of ClpAP is
further stimulated in the presence of ClpS, a ClpA-specific
adaptor protein [50]. Adaptor proteins increase the
substrate specificity of AAA+ proteins in general by trans-
targeting specific substrates to their AAA+ partner pro-
teins. Interestingly, ClpS has dual activity, as it not only
increases protein disaggregation by ClpAP, but also pre-
vents the degradation of SsrA-tagged substrates and ClpA
itself by ClpAP [50]. The influence of ClpS on protein dis-
aggregation by ClpAP can be explained by improved tar-
geting of the proteolytic system to aggregated proteins.
ClpS may also exert an indirect effect as it protects ClpA
from autodegradation, thereby ensuring constant ClpA
levels throughout the disaggregation reaction.
ClpS activity is achieved by binding to the N-domain of
ClpA [50]. The activity of ClpS is restricted to ClpA, as it
does not interact with ClpB, despite the overall similarity
between the N-domains of both AAA+ proteins. The
solved crystal structure of ClpS in complex with the N-
domain of ClpA provides a structural rationale for the
binding specificity of ClpS. Thus conserved residues of the
N-domain of ClpA, which make crucial contacts to ClpS,
are missing in the N-domain of ClpB [51]. While efficient
in degrading aggregated proteins in vitro, ClpAPS cannot
replace ClpB function in vivo [8,50]. Protein aggregates
generated upon heat shock in vivo may be different in
structure and complexity to those formed by thermolabile
model substrates in vitro. The true nature of ClpAPS sub-
strates and the in vivo function of this proteolytic system
remain unknown.
A disaggregation activity towards aggregated λ O protein
has been described for the AAA+ protein ClpX from E. coli
[52]. ClpX belongs to the class II AAA+ proteins, as it con-
sists of only one AAA domain (Fig. 2A). While efficient in
disaggregating λ O protein, ClpXP fails to solubilize other
aggregated model substrates, including Malate Dehy-
drognease (MDH) and luciferase (A. Mogk and B. Bukau,
unpublished results). One explanation for these contro-
versial results may be the size of the tested protein aggre-
gates. Generated λ O aggregates, in contrast to aggregated
MDH, can still be recovered by gelfiltration chromatogra-
phy, indicating protein aggregates of smaller size. Since
ClpA and ClpB can solubilize large-sized protein aggre-
gates (e.g. MDH aggregates) in vitro, it is tempting to spec-
ulate that the solubilization of large protein aggregates
may require a stronger force and therefore the presence of
two AAA domains. Consistent with this hypothesis, other
class II AAA+ proteins including HslU and Lon also do not
exhibit a general disaggregation activity in vitro (A. Mogk
and B. Bukau, unpublished results).
In  Bacillus subtilis, the gram-positive model organism,
ClpA and ClpB are missing. Instead B. subtilis encodes for
the AAA+ protein ClpC, which resembles ClpA and ClpB,
as it possesses an M-domain of reduced size and a ClpP
docking site (Fig. 2A). ClpC was first identified together
with its adaptor protein MecA in a genetic screen for
repressors of competence development, the ability of cellsMicrobial Cell Factories 2004, 3 http://www.microbialcellfactories.com/content/3/1/1
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to take up foreign DNA [53]. In this regulatory pathway
ClpC acts together with MecA to target the master
regulator of competence development (ComK) for degra-
dation by the ClpCP proteolytic system [54,55]. ClpC also
functions as a general stress protein. Its expression is heat
shock regulated and B. subtilis ∆clpC mutant cells are ther-
mosensitive and accumulate deposits of misfolded pro-
teins [56-58]. Furthermore, ClpC, like ClpP, localizes to
protein aggregates in heat-shocked B. subtilis cells and to
inclusion bodies formed by overexpressed insoluble het-
erologous proteins [58,59]. These data suggest that ClpC
might replace ClpB function in the gram-positive counter-
part of E. coli, although it rather links protein disaggrega-
tion to substrate degradation instead of substrate
reactivation.
A protein disaggregation activity of ClpC could be recently
reconstituted in vitro [60]. Surprisingly, ClpCP activity was
strictly dependent on the adaptor protein MecA, regard-
less of the nature of substrate. Thus ClpCP-mediated deg-
radation of the specific substrate ComK, as well as
hydrolysis of aggregated model substrates and unfolded
α-casein, occurred only in presence of MecA. Further anal-
ysis revealed that MecA has a dual functions: it delivers
substrates to ClpC and concurrently stimulates the ATPase
activity of the AAA+ protein [60]. This activity is reflected
in the domain organization of the adaptor protein: the
interaction with the ClpC partner protein is mediated via
a C-terminal domain, while substrates are recognized via
its N-domain [61]. Interestingly B. subtilis also encodes a
parologue of MecA: YpbH. YpbH can, at least in vitro, take
over MecA function and enable ClpCP to degrade aggre-
gated proteins [60]. Since B. subtilis cells lacking MecA and
YpbH function are, in contrast to ∆clpC mutant cells, not
thermosensitive, it is tempting to speculate that ClpC
activity in vivo is further controlled by other yet to be iden-
tified adaptor proteins.
Protein aggregation and neurodegenerative diseases: a 
connection to AAA+ proteins?
Protein misfolding and aggregation is thought to be cen-
tral in the pathogenesis of several neurodegenerative dis-
eases including Parkinson's disease, polyglutamine
diseases and prion diseases. In contrast to stress-generated
amorphous aggregates, disease-related protein aggrega-
tion leads to the formation of amyloid fibrils. Here we will
concentrate on polyglutamine (polyQ) diseases and their
potential connection to AAA+ proteins. PolyQ diseases
(e.g. Huntington's disease) are caused by trinucleotide
(CAG) repeat expansions. The genes responsible for these
diseases are functionally unrelated and the only known
common feature is a CAG trinucleotide repeat in each
gene's coding region, resulting in a polyQ tract in the dis-
ease protein. Expansion of this polyQ tract results in
aggregation of the corresponding proteins that is coupled
to neurodegeneration [62]. It has been proposed that pro-
teins with long polyglutamine tracts misfold and aggre-
gate as antiparallel β strands [63]. PolyQ-dependent
protein aggregation has now been demonstrated in many
different model systems, including S. cerevisiae [64],
mammalian cell-culture systems [65] and transgenic
animals [66-68]. Regulated expression of huntingtin (Htt)
exon 1 protein, which aggregates and causes toxicity in
Huntington's disease, resulted in polyQ inclusions and
neurodegeneration in a transgenic mouse model [69].
Surprisingly, when the expression of Htt exon 1 protein
was switched off after intracellular inclusion had been
formed, neurological symptoms and polyQ aggregates
disappeared [69]. These findings suggest the existence of a
disaggregation activity in mammalian cells and could
point to a potential involvement of AAA+ proteins in
polyQ aggregation.
A direct connection between AAA+ proteins and polyQ-
dependent protein aggregation could first be demon-
strated by Lindquist and co-workers. They established a
model system in S. cerevisiae to investigate the influence of
chaperones on polyQ-induced protein aggregation by fus-
ing the N-terminal region of Htt protein, carrying polyQ
tracts of variable length, to GFP [64]. Only fusion proteins
with long polyQ tracts (Q72, Q103) formed cytoplasmic
protein aggregates. Importantly, deletion of HSP104 com-
pletely blocked the formation of polyQ-aggregates and
overproduction of Hsp104 strongly reduced polyQ aggre-
gation. Similar findings were subsequently reported when
C. elegans was used as model system: expression of GFP-
polyQ82 led to protein aggregation and retarded growth
rates and both effects were reversed upon co-expression of
Hsp104 [68]. These findings are reminiscent to the influ-
ence of Hsp104 on [PSI+] propagation in S. cerevisiae, a
self-perpetuating aggregate of Sup35 (for review see [70]).
[PSI+] propagation strictly depends on Hsp104 as loss of
Hsp104 function or Hsp104 overproduction lead to cur-
ing of [PSI+] [71]. It is proposed that the fragmentation of
Sup35 fibers into shorter polymers by Hsp104 is essential
for their inheritance [72]. Overproduction of Hsp104 may
therefore cause too excessive fiber fragmentation whereas
missing Hsp104 function will lead to the formation of
large Sup35 aggregates, resulting in [PSI+] loss in either
case. Given the dependence of polyQ aggregation on
Hsp104 in yeast, it is tempting to speculate that the forma-
tion and reversion of yeast prion Sup35 and polyQ aggre-
gates may follow a common principle and that proteins
with disaggregation activities might be involved in the
development of neurodegenerative diseases in mamma-
lian cells.
A mammalian counterpart of Hsp104 has not been iden-
tified yet, however, several paralogues have been
described which may reverse protein aggregation. ToMicrobial Cell Factories 2004, 3 http://www.microbialcellfactories.com/content/3/1/1
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investigate the potential involvement of chaperones in the
propagation of neurodegenerative diseases, many
laboratories tested for the presence of chaperones in
polyQ inclusions or Lewy bodies, which are deposits of α-
synuclein. Besides Hsp70 and Hsp40 chaperones, several
AAA+ proteins were detected in such neuronal inclusions,
including VCP/p97, TorsinA and the 19S proteasomal
complexes. Since the role of Hsp70/Hsp40 proteins in
pathogenesis has been extensively described by others (for
review see [73]), we will concentrate on recent findings on
AAA+ proteins in this process.
VCP/p97 (valosin-containing protein), the mammalian
homologue of yeast Cdc48, possess two AAA domains
and is a prime candidate for representing a disaggregation
activity in mammalian cells (Fig. 2A). VCP/p97 is
involved in a variety of cellular processes, including mem-
brane fusion, protein disassembly and ubiquitin-depend-
ent degradation (for review see [74]). VCP/p97 was
shown to co-localize with polyQ-aggregates in cultured
cells and with Lewy bodies in patient samples [75].
Importantly, loss of function mutants of VCP/p97 could
suppress eye degeneration in transgenic flies, caused by
targeted expression of polyQ proteins in the Drosophila
compound eye [76]. In contrast, co-expression of VCP/
p97 with polyQ-containing proteins enhanced polyQ tox-
icity in the same study. These recent findings demonstrate
a direct influence of VCP/p97 on polyQ toxicity. Since the
curing of polyQ toxicity by VCP/p97 mutations was not
directly coupled to a loss of polyQ aggregates, it is unclear
whether VCP/p97 acted on polyQ aggregates or
influenced the aggregation process or toxicity of interme-
diate species.
Torsin A is the second mammalian AAA+ protein that may
exhibit a disaggregation activity. TorsinA is the causative
protein in the neurologic disease torsin dystonia, a move-
ment disorder [77]. TorsinA is an ER luminal protein with
a signal sequence and a short membrane-spanning
domain at the N-terminus (Fig. 2A) [78-80]. The C-termi-
nal AAA domain of TorsinA exhibits greatest homology to
Hsp104/ClpB. TorsinA was found to accumulate with α-
synuclein in Lewy bodies and to localize to sites of polyQ-
dependent protein aggregation in C. elegans [81-83]. Inter-
estingly, overexpression of TorsinA could suppress α-
synuclein aggregation in a cell culture model, whereas a
mutant TorsinA derivative had no effect [81]. Similarly,
overexpression of Torsin proteins reduced the number
and size of GFP-polyQ82 containing aggregates in C.
elegans, while a mutant Torsin variant did not [83].
PolyQ inclusions also stain positively for 20S and 19S
proteasomal complexes [84]. The 19S cap of the proteas-
ome is functionally equivalent to the AAA+ components
of ATP-dependent proteolytic systems in eubacteria and
contains a ring of six AAA+ proteins. The finding that the
addition of proteasome inhibitors caused an increase in
aggregate formation in transfected cells led to the sugges-
tion that the proteasome may be involved in polyQ
pathogenesis [85]. Other findings point to a rather indi-
rect role of proteasomes in protein aggregation. A
surprisingly high proportion (30%) of all newly synthe-
sized proteins are apparently misfolded and degraded by
proteasomes shortly after their synthesis [86]. Inhibition
of the proteasome will therefore lead to an imbalance
between the capacity of chaperones to prevent protein
aggregation and the number of aggregation-prone protein
species, resulting in increased protein aggregation. The
role of proteasomes in protein aggregation may thereby
be restricted to the degradation of misfolded substrates
before they aggregate.
To summarize, recent findings point to a potential role of
mammalian AAA+ proteins in the propagation of neuro-
degenerative diseases. Direct evidence for a disaggregation
activity of AAA+ proteins as basis for such a function is
still missing. The presence of AAA+ proteins in protein
inclusions may also only indicate an unsuccessful attempt
of these chaperones to prevent the aggregation of mis-
folded and still soluble intermediates. Similarly, reduc-
tion of protein aggregation by co-expression of AAA+
proteins in transfected cells may be caused by the interac-
tion of AAA+ proteins with such non-native intermediates
and not by the active solubilization of pre-existing protein
aggregates. Furthermore in vitro and in vivo studies are
required to investigate whether VCP/p97 or Torsin A ful-
fill a similar function in mammalian cells as ClpB/
Hsp104 does in yeast and eubacteria.
Perspectives
The discovery of the substrate-rescuing disaggregation
activity of Hsp104/ClpB revealed a new and highly
remarkable chaperone function illuminating the fate of
aggregated proteins. A disaggregation activity could now
be attributed to various eubacterial AAA+ proteins. Inter-
estingly, each AAA+ disaggregation system requires the
assistance of different cooperating proteins. Future work
will clarify how the various partner proteins affect the
mechanism of the disaggregation reaction and will lead to
a better understanding of AAA+ protein activity. So far no
orthologues of Hsp104/ClpB are evident in animal
genomes. However, recent studies on the development of
conformational diseases suggest the existence of AAA+
proteins with disaggregation activities in mammalian
cells. It will be important to obtain biochemical evidence
for this activity and to identify proteins that cooperate in
the solubilization process. Such proteins may then also
serve as therapeutic targets, potentially offering new strat-
egies in the treatment of neurodegenerative diseases.Microbial Cell Factories 2004, 3 http://www.microbialcellfactories.com/content/3/1/1
Page 10 of 12
(page number not for citation purposes)
The extraordinary chaperone activity of AAA+ proteins
may also offer a new perspective in biotechnology. High-
level expression of heterologous proteins in eubacteria
often results in the deposition of the desired product in
inclusion bodies. While this phenomenon is beneficial for
initial purification steps, it is often difficult and inefficient
to regain the functional protein. Therefore co-overexpres-
sion of chaperones and the protein of interest were per-
formed in many studies to prevent inclusion body
formation and to increase the yield of soluble, native cli-
ent protein. While this approach has been successful in a
number of cases, it failed in many others and as a conse-
quence the applications of molecular chaperones rely on
trial and error experiments [87]. The disaggregation activ-
ity of AAA+ proteins represents a new quality in the bio-
technical application of molecular chaperones, since the
co-overproduction of these systems allows transient
aggregation of heterologous proteins. Indeed, overpro-
duction of ClpB and the DnaK chaperone machinery com-
pletely solubilized the inclusion-body like aggregates
formed in E. coli ∆rpoH mutant cells after heat stress [88].
Furthermore, Villaverde and co-workers could demon-
strate that even the formation of inclusion bodies can be
reversed in E. coli cells [89]. Inclusion body disintegration
was achieved by simultaneously arresting protein synthe-
sis and lowering the growth temperature. It is tempting to
speculate that solubilization of inclusion bodies relies on
the disaggregation activity of AAA+ proteins (e.g. ClpB/
DnaK). Together these findings offer a new perspective to
increase the solubility of a wide variety of heterologous
proteins upon overproduction in eubacteria.
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